A Phase 1, Multi-Center, Open-Label Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT6021 as Mono Therapy or in Combination with BAT1308 in Patients with Advanced Solid Tumors

  • Mendis, Shehara (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

Project Description

Animal Ethics: Not required; Human Ethics: N/A (Ethics remains through Alfred as per head agreement); Gene Tech: Not required; Biosafety/Radiation: No; Split Grants: N/A
Effective start/end date28/10/2131/12/24


  • Solid tumours
  • Clinical trial
  • Oncology
  • Cancer treatment